NO783705L - Fremgangsmaate ved fremstilling av quinazolinderivater - Google Patents

Fremgangsmaate ved fremstilling av quinazolinderivater

Info

Publication number
NO783705L
NO783705L NO783705A NO783705A NO783705L NO 783705 L NO783705 L NO 783705L NO 783705 A NO783705 A NO 783705A NO 783705 A NO783705 A NO 783705A NO 783705 L NO783705 L NO 783705L
Authority
NO
Norway
Prior art keywords
procedures
preparation
quinazoline derivatives
quinazoline
derivatives
Prior art date
Application number
NO783705A
Other languages
English (en)
Other versions
NO150158B (no
NO150158C (no
Inventor
Simon Fraser Campbell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO783705L publication Critical patent/NO783705L/no
Publication of NO150158B publication Critical patent/NO150158B/no
Publication of NO150158C publication Critical patent/NO150158C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO783705A 1977-11-05 1978-11-03 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater NO150158C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4612877 1977-11-05

Publications (3)

Publication Number Publication Date
NO783705L true NO783705L (no) 1979-05-08
NO150158B NO150158B (no) 1984-05-21
NO150158C NO150158C (no) 1984-08-29

Family

ID=10439957

Family Applications (1)

Application Number Title Priority Date Filing Date
NO783705A NO150158C (no) 1977-11-05 1978-11-03 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater

Country Status (36)

Country Link
JP (1) JPS5498792A (no)
AR (2) AR219562A1 (no)
AT (1) AT365186B (no)
AU (1) AU509329B2 (no)
BE (1) BE871771A (no)
CA (1) CA1088059A (no)
CH (1) CH643255A5 (no)
CS (2) CS207671B2 (no)
DD (1) DD139850A5 (no)
DE (1) DE2847623C2 (no)
DK (1) DK154082C (no)
EG (1) EG13594A (no)
ES (2) ES474805A1 (no)
FI (1) FI64366C (no)
FR (1) FR2407929A1 (no)
GR (1) GR81514B (no)
HK (1) HK94284A (no)
HU (1) HU176306B (no)
IE (1) IE47888B1 (no)
IL (1) IL55857A (no)
IN (1) IN148828B (no)
IT (1) IT1100919B (no)
KE (1) KE3350A (no)
LU (2) LU80470A1 (no)
MY (1) MY8500286A (no)
NL (2) NL174549C (no)
NO (1) NO150158C (no)
NZ (1) NZ188813A (no)
PH (1) PH13966A (no)
PL (2) PL119419B1 (no)
PT (1) PT68735A (no)
SE (1) SE437518B (no)
SU (1) SU816403A3 (no)
UA (1) UA8324A1 (no)
YU (2) YU40204B (no)
ZA (1) ZA786184B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002644A1 (en) * 1984-11-01 1986-05-09 Takeda Chemical Industries, Ltd. 1,5-benzoxathiepin derivatives and process for their preparation
WO1985004658A1 (en) * 1984-04-04 1985-10-24 Takeda Chemical Industries, Ltd. 1,5-benzoxathiepine derivatives and their preparation
WO1985002617A1 (en) * 1983-12-14 1985-06-20 Takeda Chemical Industries. Ltd. 1,5-benzoxathiepin derivatives and process for their preparation
PT849266E (pt) * 1996-12-20 2007-03-30 Heumann Pcs Gmbh Nova forma polimorfa de mesilato de doxazosina (forma iii)
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
TW448155B (en) * 1999-03-29 2001-08-01 Dev Center Biotechnology Method for producing amide compounds and quinazolin derivatives
EP1403263B1 (en) * 2002-09-27 2005-06-22 Council of Scientific and Industrial Research Process for the preparation of N-(2,3-dihydrobenzo 1,4 dioxin-2-carbonyl) piperazine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663706A (en) * 1969-09-29 1972-05-16 Pfizer Use of 2,4-diaminoquinazolines as hypotensive agents
US3669968A (en) * 1970-05-21 1972-06-13 Pfizer Trialkoxy quinazolines

Also Published As

Publication number Publication date
DK154082C (da) 1989-02-27
NL7810909A (nl) 1979-05-08
YU255378A (en) 1983-06-30
AR223015A1 (es) 1981-07-15
FR2407929B1 (no) 1981-02-27
CS207671B2 (en) 1981-08-31
FR2407929A1 (fr) 1979-06-01
FI64366C (fi) 1983-11-10
NL174549C (nl) 1984-07-02
IL55857A0 (en) 1979-01-31
ES8308559A1 (es) 1980-07-16
SE7811382L (sv) 1979-05-06
YU40204B (en) 1985-08-31
NL174549B (nl) 1984-02-01
AU509329B2 (en) 1980-05-08
YU38683A (en) 1983-06-30
ES480121A0 (es) 1980-07-16
MY8500286A (en) 1985-12-31
NO150158B (no) 1984-05-21
NZ188813A (en) 1980-10-08
PL119419B1 (en) 1981-12-31
AU4132278A (en) 1979-05-17
JPS5498792A (en) 1979-08-03
UA8324A1 (uk) 1996-03-29
IL55857A (en) 1982-07-30
FI783347A (fi) 1979-05-06
EG13594A (en) 1982-03-31
ATA784378A (de) 1981-05-15
CS354491A3 (en) 1992-06-17
YU40419B (en) 1985-12-31
NL930062I1 (nl) 1993-09-01
DE2847623C2 (de) 1983-06-01
FI64366B (fi) 1983-07-29
GR81514B (no) 1984-12-11
PH13966A (en) 1980-11-12
SE437518B (sv) 1985-03-04
DD139850A5 (de) 1980-01-23
KE3350A (en) 1983-12-16
AT365186B (de) 1981-12-28
IN148828B (no) 1981-06-27
CH643255A5 (en) 1984-05-30
IE782179L (en) 1979-05-05
LU80470A1 (fr) 1980-06-05
AR219562A1 (es) 1980-08-29
SU816403A3 (ru) 1981-03-23
IT7829434A0 (it) 1978-11-03
JPS5625233B2 (no) 1981-06-11
CA1088059A (en) 1980-10-21
HU176306B (en) 1981-01-28
DK428678A (da) 1979-05-06
ZA786184B (en) 1979-10-31
ES474805A1 (es) 1980-01-16
NL930062I2 (nl) 1993-11-16
IT1100919B (it) 1985-09-28
PT68735A (en) 1978-12-01
PL119586B1 (en) 1982-01-30
IE47888B1 (en) 1984-07-11
PL210681A1 (no) 1979-11-05
DK154082B (da) 1988-10-10
DE2847623A1 (de) 1979-05-23
HK94284A (en) 1984-12-07
NO150158C (no) 1984-08-29
LU88331I2 (fr) 1994-05-04
BE871771A (fr) 1979-05-03

Similar Documents

Publication Publication Date Title
NO781082L (no) Fremgangsmaate ved fremstilling av jodofore forbindelser
SE7811689L (sv) Forfarande for framstellning av maytansinoider
SE7800726L (sv) Forfarande for framstellning av renat albumin
NO782484L (no) Fremgangsmaate for fremstilling av sulfobetainer
SE7804839L (sv) Forfarande for framstellning av urea
NO773682L (no) Fremgangsmaate ved fremstilling av furocumariner
NO784393L (no) Fremgangsmaate ved fremstilling av anti-allergisk aktive pyrimidin-derivater
NO781168L (no) Fremgangsmaate ved fremstilling av diasepinderivater
NO151895C (no) Fremgangsmaate for fremstilling av pyrido-indolderivater
NO783143L (no) Fremgangsmaate ved fremstilling av herpesvaksine
NO150156C (no) Fremgangsmaate ved fremstilling av 5(6)-thio-benzimidazolderivater
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
NO783705L (no) Fremgangsmaate ved fremstilling av quinazolinderivater
NO783185L (no) Fremgangsmaate ved fremstilling av serinol
NO782411L (no) Fremgangsmaate ved fremstilling av thienopyridinderivater
NO801982L (no) Fremgangsmaate ved fremstilling av svovelholdige isokinolinderivater
SE7805676L (sv) Nytt forfarande for framstellning av alkaloider av leurosintypen
NO781554L (no) Fremgangsmaate ved fremstilling av aminoalkoholderivater
NO780190L (no) Fremgangsmaate ved fremstilling av urea
NO784235L (no) Fremgangsmaate ved fremstilling av benzazepin-derivater
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
NO781111L (no) Fremgangsmaate ved fremstilling av avkoffeinert kaffe
SE7809202L (sv) Forfarande for framstellning av 2-klorsulfinylazetidin-4-oner
NO792659L (no) Fremgangsmaate for fremstilling av karbostyrilderivater